Hyperoxic injury of immature guinea pig lung is mediated via hydroxyl radicals

F J Kelly1, G Lubec

  • 1Rayne Institute, St. Thomas' Hospital, London, England.

Pediatric Research
|September 1, 1995
PubMed

Insights

Hydroxyl radicals contribute to chronic lung disease in preterm infants receiving oxygen therapy. This study identifies hydroxyl radicals as a key factor in hyperoxic lung injury, paving the way for new antioxidant therapies.

Area of Science:

  • Neonatal physiology
  • Pulmonary medicine
  • Oxidative stress research

Background:

  • Mechanical ventilation and oxygen therapy in preterm infants can cause chronic lung disease.
  • Oxidative stress from excess oxygen free radicals is implicated, but the specific radical species remain unidentified.
  • Effective antioxidant therapies for hyperoxic lung injury are currently unavailable.

Purpose of the Study:

  • To investigate the role of hydroxyl radicals, a potent reactive oxygen species, in chronic oxidative lung injury.
  • To determine if hydroxyl radicals are involved in the pathogenesis of lung damage in preterm infants exposed to hyperoxia.

Main Methods:

  • Development of a preterm guinea pig model for chronic lung injury.
  • Analysis of lung tissue for o-tyrosine, a specific biomarker of hydroxyl radical damage.
  • Quantification of N-epsilon-carboxymethyllysine to assess nonenzymatic glycosylation.

Main Results:

  • Control pups showed low levels of o-tyrosine (0.11-0.12% tyrosine) in lung tissue.
  • Hyperoxia-exposed pups exhibited progressively increasing lung o-tyrosine levels from day 7 to day 28 (0.51% to 1.45% tyrosine).
  • Significantly elevated N-epsilon-carboxymethyllysine was detected in hyperoxic pups from day 21 onwards.

Conclusions:

  • Hydroxyl radicals are identified as a significant oxidizing species contributing to hyperoxic lung injury.
  • These findings provide a molecular basis for understanding collagen deposition in the neonatal lung.
  • The study supports the development of targeted antioxidant therapies for preventing or treating chronic lung disease in preterm infants.

Related Concept Videos